Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2008
04/30/2008CN101171250A Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
04/30/2008CN101171247A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors
04/30/2008CN101171246A Stable micronized candesartan cilexetil and methods for preparing thereof
04/30/2008CN101171244A Indazolylamino quinazoline derivatives as antitumor agents
04/30/2008CN101171076A Affinity adsorbents for factor viii and von willebrand's factor
04/30/2008CN100384840C 2-pyrimidine oxy-benzoic acid [2-(pyrimidine amino methyl)]benester compound, its preparation and use thereof
04/30/2008CN100384835C Compound of biindole heterocycles, preparation method and application in use for organic electroluminescence material
04/30/2008CN100384825C Benzheterocyclic derivatives
04/30/2008CN100384424C Synergistic methods and compositions for treating cancer
04/30/2008CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/29/2008US7365211 Heterocyclic GABAA subtype selective receptor modulators
04/29/2008US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases
04/29/2008US7365199 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
04/29/2008US7365092 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
04/29/2008US7365090 Substituted phenylindoles for the treatment of HIV
04/29/2008US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
04/29/2008US7365075 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol
04/29/2008US7365073 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
04/29/2008US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide
04/29/2008US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia
04/29/2008US7364656 Triazine-based detoxification agents and their use
04/29/2008CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them
04/29/2008CA2245484C Novel urea derivatives
04/29/2008CA2218887C Piperazino derivatives as neurokinin antagonists
04/28/2008CA2666880A1 Organic compounds
04/24/2008WO2008049123A2 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
04/24/2008WO2008049116A2 Substituted indoles
04/24/2008WO2008049027A1 Talarazole metabolites
04/24/2008WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
04/24/2008WO2008047831A1 Jak inhibitor
04/24/2008WO2008046756A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
04/24/2008WO2008046657A1 Triazines and their use as inhibitors of metalloproteinases
04/24/2008WO2008046527A1 Acylaminopyrazoles for treating cardiovascular diseases
04/24/2008WO2008046216A1 Kinase inhibitors and uses thereof
04/24/2008WO2008020227A3 Antibacterial pyrrolecarboxamides
04/24/2008WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system
04/24/2008WO2008005519A3 Novel pyridazine compound and use thereof
04/24/2008WO2007106192A3 Inhibitors of iap
04/24/2008US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
04/24/2008US20080096955 Histamine-3 receptor antagonists
04/24/2008US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors
04/24/2008US20080096945 Amorphous and Crystalline Forms of Losartan Potassium and Process For Their Preparation
04/24/2008US20080096944 Preparing aqueous sodium irbesartan and displacing the sodium with magnesium or calcium ions; solvent-free; easily sterilized aqueous solutions; controlled crystallization, easy filtration and drying; nonelectrostatic behavior and ready tabletting
04/24/2008US20080096912 Indole, azaindole and related heterocyclic pyrrolidine derivatives
04/24/2008US20080096906 good affinity to the trace amine associated receptors (TAARs), especially for TAAR1; (3-Chloro-phenyl)-(1H-imidazol-2-ylmethyl)-methyl-amine from 3-chloro-N-methylaniline and imidazole-2-carboxyaldehyde and reduction of the carbonyl to methylene
04/24/2008US20080096901 Aminotriazole compounds useful as inhibitors of protein kinases
04/24/2008US20080096899 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof
04/24/2008US20080096897 water soluble; lower toxicity by photosensitization; anticancer; antitumor; antiinflammatory; arthritis; osteoporosis; ocular abnormal angiogenesis; multiple sclerosis, asthma, atherosclerosis
04/24/2008US20080096895 Heterocyclic Derivatives and Their Use as Stearoyl-Coa Desaturase Inhibitors
04/24/2008US20080096892 C-Kit Modulators And Methods Of Use
04/24/2008US20080096888 Novel compounds as opioid receptor modulators
04/24/2008US20080096886 amidation of 3-(benzyloxy)-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid via the 2-acid chloride and then reaction with an amine; hydrolysis or catalytic hydrogenation to deprotect 3-hydroxy group; high yields for industrial application; the 3-(benzyloxy)-2-carboxamide intermediate
04/24/2008US20080096883 Trifluoromethyl substituted benzamides as kinase inhibitors
04/24/2008US20080096877 Glucokinase activators; prophylaxis or treatment of diabetes, obesity; sulfonamide or sulfonate-functional thiazole or thiadiazole-substituted indoles; N,N-dimethyl-2-{4-[(2-{7-[methyl(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetamide for example
04/24/2008US20080096864 Partially imatinib-resistant tumors; synergistic; combined packaging; oral administration
04/24/2008US20080096860 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
04/24/2008US20080096220 Novel triazine-based detoxification agents and their use
04/24/2008DE102006048924A1 Acylaminopyrazole Acylaminopyrazole
04/24/2008CA2673125A1 Compositions and methods for inhibition of the jak pathway
04/24/2008CA2667053A1 Talarazole metabolites
04/24/2008CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases
04/24/2008CA2666149A1 Substituted indoles
04/24/2008CA2665255A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
04/24/2008CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
04/23/2008EP1913015A1 Macrocyclic inhibitors of hepatitis c virus
04/23/2008EP1912998A1 Pyrazole derivatives having tyrosinkinase activity
04/23/2008EP1912976A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists
04/23/2008EP1912975A1 A process for the preparation of telmisartan
04/23/2008EP1912974A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
04/23/2008EP1912972A1 Substituted imidazole compounds as ksp inhibitors
04/23/2008EP1912970A2 Acyltryptophanols for fertility control
04/23/2008EP1912966A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
04/23/2008EP1912940A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
04/23/2008EP1912939A1 Metabotropic glutamate-receptor-potentiating isoindolones
04/23/2008EP1912706A2 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors
04/23/2008EP1912662A2 Peptide deformylase inhibitors
04/23/2008EP1497269B1 Substituted 2-phenyl-3(2h)-pyridazinones
04/23/2008EP1333834B1 Antiinflammation agents
04/23/2008EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
04/23/2008CN101166737A Phosphodiesterase 4 inhibitors
04/23/2008CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors
04/23/2008CN101166730A Cinnoline compounds and their use as liver X receptor modilators
04/23/2008CN101166729A Fused heterocyclic compounds
04/23/2008CN101166726A Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
04/23/2008CN101166724A Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
04/23/2008CN101166723A New compound for the treatinginflammatory disease
04/23/2008CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
04/23/2008CN101166721A 1-acetic acid-indole derivatives with pgd2 antagonist activity
04/23/2008CN101166529A Benzotriazole derivatives as cannabinoid receptor antagonists
04/23/2008CN101165062A Novel synthesis of irbesartan
04/23/2008CN101165057A Nbeta-substituted phenyluracil compounds for removing glass
04/23/2008CN101165050A Benzoisoindole derivative, pigment composition comprising the same and colored composition
04/23/2008CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives
04/23/2008CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
04/22/2008US7361767 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna)
04/22/2008US7361719 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof
04/22/2008US7361682 Indole derivatives as H3 inverse agonists
04/22/2008US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/22/2008US7361670 Amide derivatives as NMDA receptor antagonists
04/22/2008US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia